BioXcel Therapeutics, Inc. (BTAI) › Net IncomeBioXcel Therapeutics, Inc. (BTAI) — Net IncomeAnnual figures by period end, from SEC filings.2017-12-31: -$4.54M2018-12-31: -$19.27M2019-12-31: -$32.97M2020-12-31: -$82.17M2021-12-31: -$106.93M2022-12-31: -$165.76M2023-12-31: -$179.05M2024-12-31: -$59.60M2025-12-31: -$69.90M-$69.90M2017-12-31Net Income (USD)2025-12-31Period endedNet IncomeChange YoYSource filing2025-12-31-$69.90M—2026-03-27From 2025-01-012024-12-31-$59.60M—2026-03-27From 2024-01-012023-12-31-$179.05M—2025-03-28From 2023-01-012022-12-31-$165.76M—2024-03-22From 2022-01-012021-12-31-$106.93M—2023-03-16From 2021-01-012020-12-31-$82.17M—2022-03-11From 2020-01-012019-12-31-$32.97M—2021-03-12From 2019-01-012018-12-31-$19.27M—2020-03-09From 2018-01-012017-12-31-$4.54M—2019-03-12From 2017-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)